Adenovirus type 4 a
Ended Awarded Last action
- Contract number
- SPE2DP26F5469
- Awardee
-
Teva Pharmaceuticals Usa, Inc. UEI NEN9A34LRHJ5
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $687,053
Award facts
- Contract value 100% obligated
- $687,052.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Parsippany, NJ 07054, USA
Award details come from SAM.gov/FPDS.
About this award
The Department of Defense Medical Supply Chain awarded a delivery order to Teva Pharmaceuticals USA, Inc. valued at $687,052.80 on May 11, 2026, for Adenovirus Type 4 vaccine, with ultimate completion on May 19, 2026.
The order is issued under the Defense Logistics Agency Troop Support Medical Indefinite Delivery Contract (SPE2DP20D0002), which establishes Teva as national prime vendor for Adenovirus Type 4 vaccine to support military immunization programs. This is a firm fixed-price delivery order with no set-aside applied.
Place of performance is Parsippany, New Jersey.
Quick answers
Who was awarded contract SPE2DP26F5469?
SPE2DP26F5469 was awarded to Teva Pharmaceuticals Usa, Inc. by Medical Supply Chain (Troop Support) on May 11, 2026.
How much is contract SPE2DP26F5469 worth?
The government has obligated $687,053 on SPE2DP26F5469.
Is contract SPE2DP26F5469 an order under another contract?
Yes. SPE2DP26F5469 is a delivery order under SPE2DP20D0002, an indefinite delivery contract.
Was contract SPE2DP26F5469 competed?
The extent of competition for SPE2DP26F5469 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award